Skip to main content
SpringerLink
Log in

ACMT Position Statement on Prescription Drug Shortages

  • Position Statement
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kweder SL, Dill S. Drug shortages: the cycle quantity and quality. Clin Pharmacol Ther. 2013;93:245–51.

    Article  CAS  Google Scholar 

  2. Mazer-Amirshahi M, Hawley KL, Zocchi M, Fox E, Pines JM, Nelson LS. Drug shortages: implications for medical toxicology. Clin Toxicol. 2015;53:519–24.

    Article  CAS  Google Scholar 

  3. Quadri F, Mazer-Amirshahi M, Fox ER, Hawley KL, Pines JM, Zocchi MS, et al. Antibacterial shortages from 2001-2013: implications for clinical practice. Clin Infect Dis. 2015;60:1737–42.

    Article  Google Scholar 

  4. Mazer-Amirshahi M, Goyal M, Umar SA. U.S. drug shortages for medications used in adult critical care (2001-2016). J Crit Care. 2017;41:283–8.

    Article  Google Scholar 

  5. Kaiser J. Medicine: shortages of cancer drugs put patients, trials at risk. Science. 2011;332:523.

    Article  CAS  Google Scholar 

  6. Hick JL, Hanfling D, Courtney B, Lurie N. Rationing salt water — disaster planning and daily care delivery. N Engl J Med. 2014;370:1573–6.

    Article  CAS  Google Scholar 

  7. Woodcock J, Wosinska M. Economic and techno- logical drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther. 2013;93:170–6.

    CAS  PubMed  Google Scholar 

  8. FDA Commissioner Scott Gottlieb, M.D., updates on some ongoing shortages related to IV fluids. News release of the Food and Drug Administration, Washington, DC, January 16, 2018 (https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm592617.htm). Accessed 8 Apr 2020.

  9. Langreth R, Coons CUS. U.S. hospitals face a shortage of this most basic necessity. Bloomberg Businessweek. November 14, 2017 (https://www.bloomberg.com/news/articles/2017-11-14/this-simple-lifesaving-liquid-is-suddenly-in-short-supply). Accessed 8 Apr 2020.

  10. U.S. Food and Drug Administration. FDA Safety and Innovation Act (FDASIA) Title X. http://www.gpo. gov/fdsys/pkg/BILLS-112s3187enr/pdf/BILLS-112s31 87enr.pdf. Accessed Mar 15, 2018.

  11. Mazer-Amirshahi M, Pourmand A, Singer S, et al. Critical drug shortages: implications for emergency medicine. Acad Emerg Med. 2014;21:707–11.

    Google Scholar 

  12. Institute for Safe Medication Practices. Drug shortages: national survey reveals high level of frustration, low level of safety. ISMP Med Saf Alert. 2010;15:1–4.

    Google Scholar 

  13. Hicks RW, Becker SC. An overview of intravenous-related medication administration errors as reported to MEDMARX, a national medication error-reporting program. J Infus Nurs. 2006;29:20–7.

    Article  Google Scholar 

  14. Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13:1–8.

    Article  Google Scholar 

  15. Centers for Disease Control and Prevention. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic: Nevada, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:513–7.

    Google Scholar 

  16. Johnson LA, Associated Press. Drug shortage stirs fear. Philly.com. Available at: http://www.ismp.org/ sc?k=dssf. Accessed Apr 15, 2018.

  17. Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, Higgins B, et al. Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm. 2011;68:1811–9.

    Article  Google Scholar 

  18. Premier. Taking action against drug shortages. Available at: https://learn.premierinc.com/pharmacy-and-research/taking-action-against-drug-shortages . Accessed Apr 21, 2018.

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC, USA

    Maryann Mazer-Amirshahi

  2. Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA

    Erin R. Fox

  3. Rutgers New Jersey Medical School, Newark, NJ, USA

    Lewis S. Nelson

  4. Ronald O. Perelman Department of Emergency Medicine, NYU Langone Health, New York, NY, USA

    Silas W. Smith

  5. Institute for Innovations in Medical Education, NYU Langone Health, New York, NY, USA

    Silas W. Smith

  6. Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Andrew I. Stolbach

Authors
  1. Maryann Mazer-Amirshahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erin R. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lewis S. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silas W. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrew I. Stolbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew I. Stolbach.

Ethics declarations

Conflict of Interest

None.

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mazer-Amirshahi, M., Fox, E.R., Nelson, L.S. et al. ACMT Position Statement on Prescription Drug Shortages. J. Med. Toxicol. 16, 349–351 (2020). https://doi.org/10.1007/s13181-020-00775-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-020-00775-7

Keywords

Search

Navigation